Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease

NCT06356662 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Tenofovir Disoproxil Fumarate

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine